Home/Filings/4/0001877589-24-000006
4//SEC Filing

Samaha Eli 4

Accession 0001877589-24-000006

CIK 0001583107other

Filed

Aug 8, 8:00 PM ET

Accepted

Aug 9, 6:02 PM ET

Size

5.2 KB

Accession

0001877589-24-000006

Insider Transaction Report

Form 4
Period: 2024-08-07
Samaha Eli
10% Owner
Transactions
  • Purchase

    COM

    2024-08-07$7.80/sh+999,800$7,798,4409,511,150 total(indirect: See Footnotes)
Footnotes (1)
  • [F1]These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person therein. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial owner of such securities.

Issuer

Theravance Biopharma, Inc.

CIK 0001583107

Entity typeother

Related Parties

1
  • filerCIK 0001877589

Filing Metadata

Form type
4
Filed
Aug 8, 8:00 PM ET
Accepted
Aug 9, 6:02 PM ET
Size
5.2 KB